Silver Price Forecasts: XAG/USD hits fresh two-month highs with all eyes on Jackson Hole
Silver (XAG/USD) heads north for the second consecutive day on Friday, with all eyes on the Federal Reserve (Fed) Chairman Kevin Warsh’s speech at the Jackson Hole Symposium, due later on the day. The white metal extends gains to two-month highs a few cents below $71.00, after bouncing from the mid-range of the $67.00s on Thursday, on track to close a four-week rally.
Investors await Fed Warsh’s speech, eager for further insight about the central bank’s monetary policy, following the poor guidance provided at July’s monetary policy meeting. On Thursday, Kansas Fed President Jeffrey Schmidt and Cleveland Fed President Beth Hammack called for immediate monetary tightening, following hot US Personal Consumption Expenditures (PCE) Price Index figures the previous day.
Technical Analysis: Bulls aim for the 200-day SMA, at $72.50
XAG/USD trades at $70.44 with near-term price action showing a constructive bias from July's trough below $55.00. Momentum indicators in the daily chart remain within positive territory, with the Relative Strength Index (14) at 66 approaching, but not yet at overbought levels, and the Moving Average Convergence Divergence (MACD) highlighting moderate bullish traction.
Bulls are likely to meet resistance at the mid-June highs between $71.35 and $71.55 ahead of the key resistance area at the 200-day Simple Moving Average (SMA), a closely watched indicator in FX markets, which is now lying at $72.50. A break above there would open the way toward the June 4 high near $75.00.
On the downside, Thursday's low, at $67.63, is likely to provide support, ahead of a secondary floor near $63.25, which capped bears on August 18, and the August 6 low, near $60.90.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BioXcel Therapeutics Enters Asset Sale Agreement With Teva Pharmaceuticals
Workday Raises Full-Year Subscription Revenue Outlook Following Fiscal Second-Quarter Beat
mDR reports group NTA per share at S$ 0.09 as of Aug. 27, 2026
Standard Chartered Becomes Bank Distributor for Regulated Stablecoin in Hong Kong
